Kassi Jackson Filkins, Editor

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.

Catch up on what happened in optometry during the week of June 12-June 16.

Catch up on what happened in optometry during the week of June 5-June 9.

Prevent Blindness is embarking on a new strategy to raise awareness and provide education to patients and professionals to work together to address and improve the mental wellbeing for those with vision impairment.

The clinic, connected with Transitions Academy, aims to address the unmet needs of more than 80 local Pathlight HOME clients who may have otherwise lacked access to eye exams and glasses.

The water-free, preservative-free, anti-inflammatory drop from Novaliq, now coined Vevye, received FDA approval to treat the signs and symptoms of dry eye disease.

The National Keratoconus Foundation has named NASCAR driver Joey Gase as Ambassador.

Glenda Aleman Moheeputh, OD, president and CEO of OK Love Myopia Control Experts in Florida, sat down with Optometry Times®' editor Kassi Jackson to talk about her role on the founding board of Latinos en Optometry (LEO).

The company completed enrollment in less than 6 months from the trial commencement. The phase 3 trial results combined with the completion of the first phase 3 trial are expected to support the company’s targeted NDA submission for Epioxa by the end of 2024.

Catch up on what happened in optometry during the week ofMay 29-June 2.

The move could result in changes to guidelines that currently prohibit cornea donations from gay or bisexual men who have had sex with another man in the last 5 years of their life. There's no indication as to whether other queer communities—such as transgender women or nonbinary donors—will be impacted.

Catch up on what happened in optometry during the week of May 22-May 26.

Catch up on what happened in optometry during the week of May 15-May 19.

Catch up on what happened in optometry during the week of May 8-May 12.

Acceptance is based on two phase 3 studies that demonstrated early and sustained vision improvement, meeting primary endpoint of non-inferiority compared to aflibercept.

Catch up on what happened in optometry during the week of May 1-May 5.

The co-chairs of the 2023 Controversies in Modern Eye Care symposium reflect on the day.

John Samples, MD, shares highlights from his the glaucoma panel discussion during the 2023 Controversies in Modern Eye Care meeting.

I. Paul Singh, MD, gives a brief overview of the glaucoma panel discussion during the 2023 Controversies in Modern Eye Care meeting.

Alena Reznik, MD, shares short reflections on the glaucoma panel presented during the 2023 Controversies in Modern Eye Care meeting.

Danica J. Marrelli, OD, FAAO, shares highlights from the glaucoma panel, which she was part of during the 17th annual Controversies in Modern Eye Care meeting.

Selina McGee, OD, FAAO, Dipl ABO, shares highlights from her featured symposium, "Thyroid eye disease: The masquerading eye disorder," which she co-presented during the 2023 Controversies in Modern Eye Care meeting.

Robert Maloney, MD, shares a sneak peek of his presentation and what he's looking forward to during the symposium.

Tina Mac Donald, OD, shares highlights from her presentation on living with an untreatable eye disease, which she presented during the 2023 Controversies in Modern Eye Care meeting.

Laura Periman, MD, breaks down some myths and controversies in the cosmetic world in her presentation, "Ocular toxins everywhere and in everything," presented at the Controversies in Modern Eye Care meeting.

David S. Boyer, MD, shares highlights from the symposium on advances in the geographic atrophy space, which he presented during the 17th annual Controversies in Modern Eye Care meeting.

Leo Semes, OD, shares highlights from his presentation on early detection of AMD, which he presented during the 17th annual Controversies in Modern Eye Care.

David Liao, MD, shares highlights from his discussion on evolving treatment strategies for neovascular AMD and DME, during the 17th annual Controversies in Modern Eye Care meeting.

Neda Shamie, MD, welcomes attendees to the 17th annual Controversies in Modern Eye Care meeting, and shares sneak peeks of her two presentations throughout the day.

Welcome to the 17th annual Controversies in Modern Eye Care symposium! Cochair and presenter, Dr. Arjan Hura, shares a sneak peak of his presentation later this morning.